A novel series of 3,4-disubstitutued coumarin derivatives have been synthesized by the reaction of ethyl coumarin-3-carboxylate with pyrazole-3,5-dione and condensation of ethyl 7-hydroxycoumarin-3-carboxylate with 4,6-dibromo-3-amino phenol. Acylation with acetic anhydride and condensation of coumarin derivatives with 2-hydroxybenzaldehyde yielded the corresponding acetyl derivatives and 4-substituted pyrazole derivatives. Structures of the synthesized compounds were elucidated by spectral methods and elemental analysis. All the prepared derivatives were evaluated for their cytotoxicity against human breast carcinoma cell line (MCF-7). Compound VI showed the least IC50 value in MTT colorimetric assay as compared to that of the standard marketed drug staurosporin.
Similar content being viewed by others
References
P. Roschger, W. Fiala, and W. Stadlbauer, J. Heterocycl. Chem., 29, 225 (1992).
G. Daidone, B. Maggio, D. Raffa, et al., II Farmaco, 59, 413 (2004).
L-C. Chou, L-S. Huang, J.-S. Yang, et al., Bioorg. Med. Chem., 15, 1732 (2007).
F. Manetti, C. Brullo, M. Magnani, et al., J. Med. Chem., 51, 1252 (2008)
J. Li, Y. F. Zhao, X. L. Zhao, et al., Arch. Pharm. Chem. Life Sci., 339, 593 (2006).
Y. Xia, Z.-W. Dong, B.-X. Zhao, et al., Biorg. Med. Chem., 15, 6893 (2007).
Y. Xia, C.-D. Fan, B.-X. Zhao, J. Zhao, Eur. J. Med. Chem., 43, 2347 (2008).
A. M. Farag, A. S. Mayhoub, S. E. Barakat, and A. H. Bayomi, Bioorg. Med. Chem., 16, 881 (2008).
S. Schenone, O. Bruno, A. Ranise, et al., Bioorg. Med. Chem. Lett., 14, 2511 (2004).
G. Daidone, D. Raffa, B. Maggio, et al., Eur. J. Med. Chem., 39, 219 (2004).
N. C. Warshakoon, S. Wu, A. Boyer, et al., Bioorg. Med. Chem. Lett., 16, 5687 (2006).
S. Huang, R. Lin, Y. Yu, et al., Bioorg. Med. Chem. Lett., 17, 1243 (2007).
G. D. Zhu, J. Gong, V. B. Gandhi, et al., Bioorg. Med. Chem., 15, 2441 (2007).
M. Alipour, M. Khoobi, S. Emami, et al., DARU J. Pharm. Sci., 22, 10 (2014).
I. Kostova, S. Bhatia, P. Grigorov, et al., Curr. Med. Chem., 18, 3929 (2011).
X. M. Peng, G. L. V. Damu, and Ch-He Zhou, Curr. Pharm. Des., 19, 3884 (2013).
D. A. Ostrov, J. A. Hernández Prada, P. E. Corsino, et al., Antimicrob. Agents Chemother., 51, 3688 (2007).
A. Manvar, A. Bavishi, A. Radadiya, et al., Bioorg. Med. Chem. Lett., 21, 4728 (2011).
S. Emami, A. Foroumadi, M. A. Faramarzi, Arch. Pharm. Chem. Life Sci., 341, 42 (2008).
R. V. Nair, E. P. Fisher, S. H. Safe, et al., Carcinogenesis, 12, 65 (1991).
B. Yuce, O. Danis, A. Ogan, et al., Arzneim.-Forsch. Drug Res., 59, 129 (2009).
K. V. Sashidhara, A. Kumar, M. Chatterjee, et al., Bioorg. Med. Chem. Lett., 21, 1937 (2011).
S. F. Razavi, M. Khoobi, H. Nadri, et al., Eur. J. Med. Chem,. 64, 252 (2013).
A. Asadipour, M. Alipour, M. Jafari, et al., Eur. J. Med. Chem., 70, 623 (2013).
M. Alipour, M. Khoobi, A. Moradi, et al., Eur. J. Med. Chem., 82, 536 (2014).
S. M. Bagheri, M. Khoobi, H. Nadri, et al., Chem. Biol. Drug. Res., 86, 1215 (2015).
M. Campos-Toimil, F. Orallo, L. Santana, and E. Uriarte, Bioorg. Med. Chem. Lett., 12, 783 (2002).
D. Sigh and D. P. Pathak Anjali, Int. J. Pharm. Sci. Res., 7, 482 (2016).
J. Klenkar and M. Molnar, J. Chem. Pharm. Res., 7, 1223 (2015).
J. Marco-Contelles, E. Pérez-Mayoral, and P. Ballesteros, CHEC III, 199 (2008).
I. M. El-Deen, M. S. A. Elgareib, A. R. E. Mahdy, and M. S. Saleem, Mens. Agitat., 13, 10 (2018).
M. K. Shim, H. Y. Yoon, S. Lee, M. K. Jo, et al.. Sci. Rep., 7, 16635 (2017).
Acknowledgements
The authors are thankful to nuclear magnetic resonance lab in faculty of pharmacy, Mansoura University and nuclear magnetic resonance lab in Beni-suef University for using their laboratory equipments during this work.
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human participants or animals performed by any of the authors in this work.
CONFLICT OF INTERESTS
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Radwan, E.M., Elsayed, E.H., El-Moneim, M.A. et al. Synthesis and Cytotoxicity Against Human Breast Carcinoma Cell Evaluation of Some New 3,4-Disubstituted Coumarin Derivatives. Pharm Chem J 55, 1040–1049 (2022). https://doi.org/10.1007/s11094-021-02535-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02535-5